(DAPT) in patients treated with Firehawk stents was non-inferior to 12 months of DAPT for the primary composite event of ...
Adnan and colleagues evaluated machine learning models’ ability to screen for Parkinson’s disease using self-recorded smile videos. 2. The models achieved high sensitivity and specificity among ...
Among patients with acute pancreatitis (AP), a history of atrial fibrillation (AF) was associated with increased disease ...
Obstructive Sleep Apnea Risk and Mental Health Conditions Among Older Canadian Adults in the Canadian Longitudinal Study on ...
Etomidate is associated with significantly higher in-hospital 7- and 28-day mortality compared with ketamine in rapid ...
An intervention to increase point-of-care ultrasound-guided regional anesthesia (POCUS-GRA) uptake by emergency physicians was safe, effective, and significantly reduced the odds of delirium. Evidence ...
In this updated systematic review, cannabis-based products with a comparable or high tetrahydrocannabinol (THC)-to-cannabidiol (CBD) ratio may provide a small reduction in chronic pain severity. 2.
1. Use of guideline-directed medical therapy (GDMT) in heart failure with reduced ejection fraction (HFrEF) and heart failure with mildly reduced ejection fraction (HFmrEF), and sodium–glucose ...
Use our free Physician Fee Schedule (PFS) and RVU lookup tool to search the latest CMS Medicare Physician Fee Schedule data quickly using natural languge (like “liver biopsy”). The tool will match the ...
In a large randomized trial of adolescent girls, one dose of either the bivalent or nonavalent human papillomavirus (HPV) vaccine was noninferior to two doses in preventing persistent high-risk HPV ...
1. In this randomized controlled trial, gene-editing therapy targeting the kallikrein B1 gene (KLKB1) led to a significant reduction in plasma kallikrein levels among adults with hereditary angioedema ...
Study Rundown: In patients with HER2-positive early breast cancer, treatment commonly includes neoadjuvant chemotherapy with agents like trastuzumab, a HER2-targeted therapy. However, over half of ...